Joe Bellino
Analyst · Noble Financial. Please proceed sir
Thank you, Tony, and good morning everybody, we appreciate you being on the call this early. As Tony mentioned we are deeply disappointed in the employees' misconduct and the weaknesses in our internal controls over financial reporting that have lead to restatements in certain prior periods. We take this matter very seriously and are working diligently to implement the necessary corrective actions. We’re in the process of remediating four material weaknesses, three related to a long-term contract initiated in prior periods, following the discovery of misconduct by employees which resulted in the identification of a forward loss reserve and this should have been recorded in 2009, the prior period. In addition a fourth material weakness was recognized related to income tax errors in the year-end reconciliation of income taxes for payables and deferred assets and deferred tax balances, primarily in 2013, 2012 and 2011. We expect to remediate the forward loss contract material weaknesses by the end of the third quarter this year and the tax adjustment weaknesses by year-end as they are year-end entity controls. The 10-K results which we released this morning for fiscal 2014 include restatements of certain previously issued financial statements and the selected financial data. Want to try to quantify the effect of that; the restatement has the following effect on our financial statements. Net income increased $1 million or $0.09 per fully diluted share for the nine months ended September 27, 2014. Net income increased 2 million or $0.19 a share for fully diluted share for fiscal 2013. Net income increased $1.2 million or $0.11 per fully diluted share for fiscal 2012. These are all compared to what was previously reported. Our shareholders’ equity was reduced by 4.4 million as of September 27, 2014. The restatement had no effect on our revenues or our cash flows from operations. Now turning to our financial results. Looking at the fourth quarter results net sales for the quarter were approximately 188 million that was very similar to last year’s fourth quarter. The revenue does reflect to the continuing shift in demand that we’ve seen throughout the second half of 2014 with a strong 25% increase in revenues for the commercial aerospace shipments and they’re being offset by an 18% decrease in military and space sales both structural and electronics products. Within the commercial aerospace sector we saw increases in both structures and electronic solutions, as we continue to benefit from higher airframe build rates and increased content. Conversely in the military and space sector we have seen reduced demand in both structural solutions and technology applications reflecting lower aggregate demand for government defense spending. We expect these mix shift trends as well as overall levels of demand to continue through the first half of 2015. Ducommun's net income for the fourth quarter of 2014 was 5.2 million, that’s $0.46 per fully diluted share compared to a loss of 5.2 million or $0.49 per diluted share in the fourth quarter of 2013. As previously reported in '13, when we reported our results for the fourth quarter, the net loss included charges of 8.8 million or $0.51 per share after tax, it was comprised of two pre-tax program related charges of 14 million that were somewhat offset by reduced accrued compensation expenses in that period of approximately $5.3 million. Fourth quarter 2014 net income was favorably impacted by an insurance recovery, we also saw one in the third quarter and increases in income from a favorable customer settlement resulting in a modest benefit from the reversal of the forward loss reserve. The fourth quarter also benefited from a favorable income tax rate which was partially offset by higher accrued compensation and benefit cost in our fourth quarter. In the fourth quarter legislation was passed to approve the research and development tax credit and we recognized a 2.4 million or $0.21 per fully diluted share benefit as compared to last year’s comparable period where we have recognized $0.8 million benefit in the fourth quarter or approximately $0.07 per diluted share. The reason I talk about these are that in 2013 and legislation was approved on January 2nd so we took approximately 0.7 to 0.8 million a period or $0.07 a share throughout the four quarters in '13 whereas in '14. We only recognized the R&D tax credit benefit of $0.21 in that period so as we look at it the delta was $0.14 on a true run rate year-over-year. Regarding the availability of federal R&D tax credits in 2015 as legislation has not been passed this year, we do not expect to record any related R&D tax benefit until or such legislation is passed, as a result we expect a normalized tax rate of 31% throughout each reporting period in 2015. Operating income for the fourth quarter was 10 million or 5.4% of revenues very similar to the amount reported in the third quarter 2014. This reflects the environment and the shift in business mix we experienced in the latter half of the year including the two military programs that Tony spoke about that are winding down. Our gross margin of 17.9% was slightly higher than the 17.6% gross margin in third quarter of 2014. We are addressing the impact of mix shift and gross margin levels and taking action by rightsizing our manufacturing cost structure to adapt to these changes. Higher accrued compensation cost resulted in selling, general and administrative expenses running above 12.6% of revenues resulting in an operating margin of 5.4%, again this was very similar to the amount we reported in our third quarter of 2014. Including the current quarter results was $1 million insurance recovery related to property and equipment which is classified in other income. EBITDA was $18.2 million or approximately 9.7% of revenues in our fourth quarter. In reviewing results by each of the business segments, first Ducommun AeroStructures, DAS. DAS reported sales of 78 million in the fourth quarter as compared to 81 million in last year’s prior period. DAS revenue was unfavorably impacted by a 27% decrease in military and space sales, primarily due to the reductions in the C-17 as the contract ended in the fourth quarter and Apache main rotor which has seen reduced customer requirements. Partially offsetting the military and space declines was an 18% increase in commercial aerospace revenues driven by solid growth of Boeing and Airbus shipments. Along with an increase in sales of regional and business jet applications. DAS's operating income was 6.9 million or 8.8% of revenue similar to the third quarter of 2014. Segment operating income was favorably impacted by the reversal of forward loss reserve a result of a customer settlement. Partially offset by higher accrued compensation and benefit costs. Our EBITDA in the DAS sector was 10.5 million or 13.5% of revenues. Now, next in reviewing Ducommun and LaBarge Technologies or DLT segment. Net sales for the fourth quarter of 2014 were 109 million as 2% increase compared to last year’s comparable period. That said, we have modest shift as defense electronic sales declined by 8 million, they were offset by increases in commercial aerospace electronics revenue which were up 5 million and $5 million increase in non A&D sales. We attribute the decrease in defense technologies applications revenues primarily because of reductions in funding for F-18 modernizations affecting our radar rack applications and softness in military helicopter demand. In recent years we have seen sequential declines in our defense electronics backlog but we continue to see higher demand for our commercial aerospace electronics. And our non A&D offerings both the result of recent business development initiatives. However, while revenue within the natural resources sector was solid for the quarter and for the year, we are now seeing the adverse impact of the changing dynamics in the energy markets including higher oil prices. And this is being reflected on our sequential decline in current backlog. DLT’s operating income for the fourth quarter of '14 was 8.5 million or 7.8% of revenue that compares to 9.4 million or 8.8% of revenue in '13. The decrease reflects an unfavorable product mix, higher manufacturing costs and accrued compensation and benefit expenses. They are partially offset by higher revenues. We are currently addressing and taking action on the level of manufacturing expenses and are aggressively pursuing cost reduction activities and supply chain initiatives and they’re improving operating performance. EBITDA was 13 million during the quarter or 11.9% of revenue compared to 13.9 million or 13% of revenue in last year’s comparable period. Corporate, general and administrative expenses which Ron allocated to the business segments for the fourth quarter of 2014 were 5.3 million or 2.8% of revenue, compared to 3.5 million or 1.9% of revenue in last year’s comparable period, primarily as a result of higher accrued compensation and benefit expenses this year as compared to last year. Our overall backlog at the end of the quarter was 559 million. This equates to a sequential decrease of 10 million versus Q3 2014 and reflects a $13 million decline in our military and space backlog, a $7 million increase in commercial aerospace products and a $4 million reduction in demand for industrial and energy application. As I mentioned most of those are really related to the slowdown and backlogs on the energy sector, we’re working diligently to finalize additional orders across various commercial aerospace and defense technology platforms in the upcoming half of this year consistent with normal seasonal patterns. We now turn to liquidity and capital resources. Earlier Tony mentioned that during the quarter we continued to de-lever our balance sheet and generate very solid cash flows. In 2014 we generated a record 53 million in cash flow from operations, compared to just under 46 million in full year 2013. We generated approximately 38 million in free cash flow which is approximately $3.40 per fully diluted share and use all of that and some cash on hand in our balance sheet to repay nearly 43 million in debt in 2014. We remained diligent in effective working capital management and expect our net cash profile going forward to reflect historic seasonal patterns. We ended the year with sufficient cash balances and expect to continue deleveraging the balance sheet. At year-end, our net debt to adjusted EBITDA was approximately 3:1. During the first quarter of 2015, we also made another $10 million prepayment on our term loan debt in our -- and we have not reduced our total funded debt to $280 million. At this stage we are on schedule with regards to our goal of deleveraging to targets of 2.75 to 3 by year-end 2015. In addition, we recognized that we may have the opportunity this year to refinance our debt and reduce interest expense significantly going forward as well as increase our ability to execute on our strategic growth initiatives. Capital expenditures for fiscal 2014 were 18 million, we expect them to be 15 million in fiscal 2015. In closing, as we continue to focus on managing the changing mix in our business addressing manufacturing costs and pursue supply chain savings and opportunities to support our goal of achieving sustained operating and EBITDA margin which along with diligent and frugal expense management and a focus on working capital efficiency should permit the company to generate meaningful free cash flow going forward. And with that, I'd like to turn it back to Tony for his closing remarks. Tony?